Sanofi CEO says focusing on smaller, 'bolt-on' deals, WSJ reports

Christopher Viehbacher, the CEO of Sanofi, says his company will continue to focus on smaller, "bolt-on" acquisitions despite the resurgence of much bigger deals in the sector, the Wall Street Journal reports. He comments, "And because we believe that we have critical mass in these areas, we don't feel the need to pay any price to acquire further businesses."

Advertisement